The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
Posted on: Wednesday, 18 February 2009, 07:35 CST
OTTAWA,
The Medizone AsepticSure(TM) system is described as a portable decontamination and sterilization system for hospitals, government buildings, schools and other functionally critical environments that might currently require, or need to be prepared for, countermeasures capability from contamination by infectious biological agents such as C difficile, E coli, Pseudomonas aeruginous, MRSA and VRE. The AsepticSure(TM) system is designed to sterilize the space and then return it to full service in two hours or less.
Dr. Shannon stated that "this research partnership is the first for the
Foundation and he expects that it will establish a model for other projects in
the future. Presently, the Foundation is fully occupied in developing this
sterilization program. We are currently identifying principal investigators as
well as a suitable research institution at which we plan to focus most of our
microbiology for this exciting project. Our intention is to begin independent
university trials in the spring with the goal of validating the effectiveness
of our new system across a broad range of bacterial and viral pathogens. This
will be quickly followed by actual hospital beta testing to confirm the
practicability of our decontamination protocols. Based upon innovative new
engineering approaches, we remain confident that this research will reliably
demonstrate 5 log reductions for most, if not all, of these often fatal
bacteria. The implications of such work are indeed profound as these pathogens
are considered to be the main causative agents of hospital derived infections
and collectively account for tens of thousands of lives lost each year in the
US alone. So far we have received a high level of interest from hospitals in
both
The Canadian Foundation for Global Health is a federally chartered not for profit Canadian Corporation. It has been established to assist in the research and development of novel and advanced emerging technologies in the field of science and medicine deemed to be of benefit to humanity.
Medizone International, Inc., is a research and development stage company engaged in the development of patented and unpatented technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to decontaminate and sterilize hospital surgical suites, emergency rooms and intensive care units.
This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Contact for the Canadian Foundation for Global Health 613-231-8555
Investor Relations, Medizone International: 800-953-3350 /
web site: www.medizoneint.com
SOURCE Medizone International, Inc.
Source: PR Newswire
Related Articles
- Dr. Susan Blumenthal, Meridian International Center's Global Health Chair, Named Health Leader of the Year
- Yingli Green Energy, Energy Research Centre of the Netherlands and Amtech Systems Announce Research Collaboration to Develop Next Generation High Efficiency Solar Cells
- ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinson's Disease Research to Develop Tolls for Imaging Alpha-Synuclein Aggregation in Living Parkinson's Brain
- Research International Delivers a Revolutionary STM Model
- Skylight Healthcare Systems Adds Three Luther Midelfort-Mayo Health System Hospitals in Wisconsin
- Hebei World Friendship Hospital's Research Project 'Water-Soluble No. O Burn Gel' is Ready for Clinical Experiment for Second and Third-Degree Burn Treatment, Reports Sunnylife Global, Inc.
- Topical Hydrotherapy Pioneer and Bio-Logic Aqua Research Founder Sharon Kleyne to Preview the '2007 International Symposium on Occupational Health and Eyesight Wellness Responsibility' - on Jan. 30 at the Beverly Hilton Hotel at 12:30pm
- Wolters Kluwer Health to Package New Therapeutic Insights & Review With Hospital Pharmacy, the Nation's Most-Read Health-System Pharmacy Journal
- Research and Markets: Analysis of Health Insurance at an International Level
- CORRECTING and REPLACING California HealthCare Foundation and the Center for Health Research, UC Berkeley Co-Host Health Care Information Technology Conference
 |
 |
User Comments (0)
RSS Feeds